drugset / Trial / NCT02140125
A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of single subcutaneous dose of ASP2408 in non-elderly healthy adult male subjects. The pharmacodynamics of ASP2408 is also being evaluated.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP2408 | Unknown | — | Subcutaneous |
Indications
No indication recorded.